The Latest in Multiple Sclerosis

Neurology Reviews

Alemtuzumab May Prevent MRI Lesions for Six Years in Patients With Highly Active Disease

May 31, 2017

Multiple Sclerosis

Neurology Reviews

What Are Patients With MS Saying About Day-to-Day Life and Treatment?

May 31, 2017

Multiple Sclerosis

Neurology Reviews

Siponimod Reduces Risk of Confirmed Disability Progression in Secondary Progressive MS

May 31, 2017

Multiple Sclerosis

Neurology Reviews

How Can We Predict Whose MS Will Worsen?

May 31, 2017

Multiple Sclerosis

Neurology Reviews

Preliminary Study Suggests Possible New Treatment for Progressive MS

May 31, 2017

Multiple Sclerosis

Neurology Reviews

Should Patients on B Cell–Depleting Therapies Be Immunized Against Influenza?

May 26, 2017

Multiple Sclerosis

Neurology Reviews

Does a High-Quality Diet Affect Disability Status in Patients With MS?

May 26, 2017

Multiple Sclerosis

Neurology Reviews

Light Physical Activity May Improve Physical Function in Older Patients With MS

May 26, 2017

Multiple Sclerosis

Neurology Reviews

Number Needed to Treat Analyses Comparing Alemtuzumab With Ocrelizumab

May 26, 2017

Multiple Sclerosis

Neurology Reviews

MS May Have a Measurable Prodrome

May 25, 2017

Multiple Sclerosis

Neurology Reviews

Pooled Data Show Benefits of Cladribine Tablets on Relapse Rates and Disability Progression in Patients With MS

May 25, 2017

Multiple Sclerosis

Neurology Reviews

Preliminary Results Suggest Ublituximab Is Safe in Relapsing Multiple Sclerosis

May 25, 2017

Multiple Sclerosis

Neurology Reviews

MRI Lesion Activity and Relapses May Predict Short- and Long-Term Outcomes in MS

May 25, 2017

Multiple Sclerosis

Clinical Neurology News

Study supports link between pediatric MS and remote viral infections

May 17, 2017

Neurology Reviews

How Often Is Optic Neuritis Misdiagnosed?

May 4, 2017

Multiple Sclerosis